THE ROLE OF THE NURSE IN THE CARE OF NEPHROLOGY PATIENTS AND THE IMPORTANCE OF TRAINING IN THIS FIELD
DOI:
https://doi.org/10.61841/ksdzt609Keywords:
Nurse, nephrology patient,training, patient management.Abstract
The purpose of the study is to observe the role of nursing in the care of nephrology patients and the importance of their training in this field.This study is a retrospective descriptive type.In this study included a total of 160 licensed nurses with an average age of 41.5 ± 12.63 years.The study was conducted in a period of 2013-2015 in several regional hospitals in the country.The data were analyzed and certain conclusions drawn by SPSS version 15.00.The value p <0.05 was considered statistically significant.Tables and graphs are used for data visualization160 nurses obtained from the study showed that the average age was 41.5 ± 12.63 years.Noticed a predominance of women 102 (3.75%) compared with 58 men (36.25%).The study shows that 43 (26.88%) of individuals have continuing nursing care training versus 117 (73.13%) of individuals who do not have this training.The study shows that 117 individuals or 73.13% participate in workshops on continuing nursing management versus 43 individuals or 26.88% who do not participate in these continuing nursing care trainings.t =
0.206 indicating that there is no statistically significant difference between the two variables.P = 0.01. On the basis of the distribution of time nursing spends in treating patients with nephrologic problems we obtain the followingresults:Hemodialysis 19.3 or 20%.Peritoneal dialysis 12.57 or 13%, Management of chronic renal disease
19.03 or 20%, Continuous renal replacement therapy 7.1 or 8%, Acute care 22.55 or 21%.Overall nephrology 14 or 15%.The data collected showed that there are specific aspects of SRK in patient management that put out that nurses had an extremely heavy role in assessing, monitoring and health education and it needed improvement continuous training and their certification
Downloads
References
1. Carnevali.D.L.1983,Gordon M.1982,Nursing care planiong,Diagnosis and management,Nursing diagnosis process and application.
2. Carpenito.L.J.1983,Nursing diagnosis,Application to clinical practice.
3. Centers for Disease Control. (2005). Infection control for peritoneal dialysis patients.
4. Centers for Disease Control. (2005). Infection control for peritoneal dialysis patients. Retrieved August 26, 2007 from http://www.bt.cdc.gov/disasters/pdf/ icfordialysis.pdf
5. Centers for Disease Control. Recommended infection control practices for hemodialysis units. Retrieved September 9, 2007 from 71
6. Chauhan V, Vaid M (November 2009). "Dyslipidemia in chronic kidney disease: managing a high-risk combination". Postgrad Med 121 (6): 54–61.
7. Dinwiddie, L.C. & Colvin, E.R. (2006). End-of-life care in the chronic kidney disease population. In Molzahn, A. & Butera, E. (Ed.) Contemporary nephrology nursing: Principles and practices (2nd ed.) New Jersey: Anthony Janetti.
8. Dr Andy Stein (2007-07-01). Understanding Treatment Options For Renal Therapy. Deerfield, Illinois: Baxter International Inc. p. 6. ISBN 1-85959-070-5
9. Dr Per Grinsted (2005-03-02). "Kidney failure (renal failure with uremia, or azotaemia)". Retrieved 2009- 05-26.
10. JaanetteK.Chambers 27.Chronic renal failure(2112-2147) Intervetions for client with renal disorders
11. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. Jul 20 2013;382(9888):260-272.
12. Johnson, David (2011-05-02). "Chapter 4: CKD Screening and Management: Overview ". In Daugirdas, John. Handbook of Chronic Kidney Disease Management. Lippincott Ë illiams and Ëilkins. pp. 32–
43. ISBN 1-58255-893-0
13. Kelly, K. (2004). How peritoneal dialysis works. Nephrology Nursing Journal, 31(5), 481-489
14. Kidney Disease Improving Global Outcomes (August 2009). "KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)" (PDF). Kidney Int 76 (Suppl 113).
15. Kidney Disease Improving Global Outcomes (January 2013). "KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease" (PDF).Kidney Int Suppl 3 (1): 1–150. Retrieved 5 February 2016.
16. Leininger M.1982,The essence of nursing and health.
17. Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, Burns K, (November 2008). "Guidelines for the management of chronic kidney disease". CMAJ179 (11)
18. Medical Surgical Nursing:A nursing process approach(2nd edition)Volume II.
19. Medical Surgical Nursing:A nursing process approach(2nd edition)Volume II.
20. Medical Surgical Nursing:A nursing process approach(2nd edition)Volume II
21. MedicineNet, Inc. (2008-07-03). "Hyperkalemia". Retrieved 2009-05-26..
22. National Institute for Health and Clinical Excellence. Clinical guideline 73: Chronic kidney disease. London, 2008.
23. National Kidney Foundation (2002). "K/DOQI clinical practice guidelines for chronic kidney disease". Retrieved 2008-06-29.
24. Nephrology nursing scope and standards of practice (7th ed., pp. 1-13). Pitman, NJ: American Nephrology Nurses' Association. (certain chapter(s) ë ithin the book).
25. Nursing scope and standards of practice (7th ed.). Pitman, NJ: American Nephrology Nurses' Association. (ëhole book in general) or Gomez, N. (Ed.) (2011).
26. Peplau,H.E.1952,Interpersonal relation in nursing.
27. Qaseem A, HopkinsRH, Sëeet DE, Starkey M, Shekelle P (22 October 2013). "Screening, Monitoring, and Treatment of Stage 1 to 4 Chronic Kidney Disease: A Clinical Practice Guideline From the Clinical Guidelines Committee of the American College of Physicians.". Annals of Internal Medicine 159 (12): 835–47.
28. Steckles ,S,B.1982 .Predicting,measuring,implementing and folloëing up on patient.
29. Swearingen P.L,Manual of nursing therapeutics,Applying nursing diagnoses to medical disorders.
30. YuraH.andWalsh.M.B.1983.Thenursingprocess,Assessing,Planning,implementing evaluating.
31. Alankar Shrivastava. "Analytical Methods for Venlaflaxine Hydrochloride and Metabolites Determinations in Different Matrices." Systematic Reviews in Pharmacy 3.1 (2012), 42-50.
32. Sasikala, V.P., & Dharmalingam, R. (2016). An Optimized Design of Approximate Multiplier by Partial Product Preforation. International Scientific Journal on Science Engineering & Technology, 19(7), 150- 156.
33. Nithya,V., and Jeeva,B. (2017). User Product Recommendation from Social Media. Excel International Journal of Technology, Engineering and Management, 4(1), 52-54.
34. Chitra, R., Seenivasagam, V. Heart disease prediction system using supervised learning classifier. Bonfring (2013) Int. J. Softw. Eng. Soft Comput, 3 (1), pp. 1-7.
35. Parsana, T.S., Patel, M.T. A Case Study: A Process FMEA Tool to Enhance Quality and Efficiency of Manufacturing Industry (2014) Bonfring International Journal of Industrial Engineering and Management Science, 4 (3), pp. 145-152.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
